Latest filing published 02 Jun 2017 for BELLUS Health Inc., €60k.
Pharmascience Inc. discloses dealings in BELLUS Health Inc. to SEDI. In total, 4 filings cover trades dated from 25 May 2012 to 30 May 2017.
No open-market purchase appears, only 2 sales worth €104k. So far in 2017, the count stands at no purchases and 2 sales.
Most recently, on 2 June 2017, the filings show an open-market sale worth €60k in BELLUS Health Inc. Typically, a trade is published a median of 5 days after it takes place. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations